Cost-effectiveness of rivaroxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation in the Japanese healthcare setting

Masatsugu Hori, Norio Tanahashi, Sayako Akiyama, Grace Kiyabu, Julie Dorey, Rei Goto